CHICAGO, IL USA (UroToday.com) - Presented by Bruce Montgomery,1 on behalf of Thian Kheoh,2 Arturo Molina,2 Jinhui Li,3 Joaquim Bellmunt,4 Charles J. Ryan,5 NamPhuong Tran,2 Yohann Loriot,6 Eleni Efstathiou,7 Howard I. Scher,8 Johann S. de Bono9 at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 31 - June 4, 2013 - McCormick Place - Chicago, IL USA
1University of Washington, Seattle, WA; 2Janssen Research & Development, Los Angeles, CA; 3Janssen Research & Development, Raritan, NJ; 4Dana-Farber Cancer Institute, Boston, MA; 5Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; 6Institut Gustave Roussy, Villejuif, France; 7The University of Texas MD Anderson Cancer Center, Houston, TX, University of Athens, Greece; 8Memorial Sloan-Kettering Cancer Center, New York, NY; 9The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK
R. Bruce Montgomery, MD is associate professor, Medical Oncology Division, University of Washington School of Medicine; affiliate member, Clinical Research Division, Fred Hutchinson Cancer Research Center; and medical oncologist, Seattle Cancer Care Alliance
He received his medical degree from Duke University School of Medicine, did residency at Brigham and Women's Hospital's internal medicine division and his fellowship at the University of Washington in the division of medical oncology.
His areas of clinical expertise include treatment of high risk and advanced prostate cancer, treatment of bladder and testicular cancers, and drug resistance to hormonal therapy and taxane chemotherapy.